Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 3 , Pages 361-373 , June 2009

Cardiovascular risk assessment of the diabetic patient undergoing major noncardiac surgery

  • Sanne Hoeks, MSc

      Affiliations

    • Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Willem-Jan Flu, MD, Doctor

      Affiliations

    • Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Jan-Peter van Kuijk, MD, Doctor

      Affiliations

    • Department of Anesthesiology, Erasmus Medical Center, Rotterdam, The Netherlands
    • ,
  • Jeroen Bax, MD, PhD, Professor

      Affiliations

    • Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands
    • ,
  • Don Poldermans, MD, PhD, Professor

      Affiliations

    • Department of Vascular Surgery, Erasmus Medical Center, Rotterdam, The Netherlands
    • Corresponding Author InformationCorresponding author. Erasmus Medical Center, Room H805, 's-Gravendijkwal 230, 3015 CE Rotterdam, The Netherlands. Tel.: +31 10 7034613; Fax: +31 10 7034957.

References 

  1. Mangano DT. Perioperative cardiac morbidity. Anesthesiology. Jan 1990;72(1):153–184
  2. Poldermans D, Hoeks SE, Feringa HH. Preoperative risk assessment and risk reduction before surgery. Journal of the American College of Cardiology. May 20 2008;51(20):1913–1924
  3. Mangano DT, Hollenberg M, Fegert G, et al. Perioperative myocardial ischemia in patients undergoing noncardiac surgery–I: Incidence and severity during the 4 day perioperative period. The Study of Perioperative Ischemia (SPI) Research Group. Journal of the American College of Cardiology. Mar 15 1991;17(4):843–850
  4. Janand-Delenne B, Savin B, Habib G, et al. Silent myocardial ischemia in patients with diabetes: who to screen. Diabetes Care. Sep 1999;22(9):1396–1400
  5. London MJ, Hollenberg M, Wong MG, et al. Intraoperative myocardial ischemia: localization by continuous 12-lead electrocardiography. Anesthesiology. Aug 1988;69(2):232–241
  6. Cohen MC, Aretz TH. Histological analysis of coronary artery lesions in fatal postoperative myocardial infarction. Cardiovascular Pathology. 1999;8(3):133–139
  7. Goldman L, Caldera DL, Nussbaum SR, et al. Multifactorial index of cardiac risk in noncardiac surgical procedures. The New England Journal of Medicine. Oct 20 1977;297(16):845–850
  8. Detsky AS, Abrams HB, Forbath N, et al. Cardiac assessment for patients undergoing noncardiac surgery. A multifactorial clinical risk index. Archives of Internal Medicine. Nov 1986;146(11):2131–2134
  9. Lee TH, Marcantonio ER, Mangione CM, et al. Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery. Circulation. Sep 7 1999;100(10):1043–1049
  10. Boersma E, Kertai MD, Schouten O, et al. Perioperative cardiovascular mortality in noncardiac surgery: validation of the Lee cardiac risk index. American Journal of Medicine. Oct 2005;118(10):1134–1141
  11. Rabbitts JA, Nuttall GA, Brown MJ, et al. Cardiac risk of noncardiac surgery after percutaneous coronary intervention with drug-eluting stents. Anesthesiology. Oct 2008;109(4):596–604
  12. Rockman CB, Saltzberg SS, Maldonado TS, et al. The safety of carotid endarterectomy in diabetic patients: clinical predictors of adverse outcome. Journal of Vascular Surgery. Nov 2005;42(5):878–883
  13. Juul AB, Wetterslev J, Kofoed-Enevoldsen A. Long-term postoperative mortality in diabetic patients undergoing major non-cardiac surgery. European Journal of Anaesthesiology. Jul 2004;21(7):523–529
  14. Axelrod DA, Upchurch GR, DeMonner S, et al. Perioperative cardiovascular risk stratification of patients with diabetes who undergo elective major vascular surgery. Journal of Vascular Surgery. 2002;35(5):894–901
  15. Hamdan AD, Saltzberg SS, Sheahan M, et al. Lack of association of diabetes with increased postoperative mortality and cardiac morbidity: results of 6565 major vascular operations. Archives of Surgery. Apr 2002;137(4):417–421
  16. Halm EA, Tuhrim S, Wang JJ, et al. Risk factors for perioperative death and stroke after carotid endarterectomy. Results of the New York carotid artery surgery study. Stroke. Oct 23 2008;
  17. Tu JV, Wang H, Bowyer B, et al. Risk factors for death or stroke after carotid endarterectomy: observations from the Ontario carotid endarterectomy registry. Stroke. Nov 2003;34(11):2568–2573
  18. Kragsterman B, Logason K, Ahari A, et al. Risk factors for complications after carotid endarterectomy–a population-based study. European Journal of Vascular and Endovascular Surgery. Jul 2004;28(1):98–103
  19. Ahari A, Bergqvist D, Troeng T, et al. Diabetes mellitus as a risk factor for early outcome after carotid endarterectomy–a population-based study. European Journal of Vascular and Endovascular Surgery. Aug 1999;18(2):122–126
  20. Ballotta E, Manara R, Meneghetti G, et al. Diabetes and asymptomatic carotid stenosis: does diabetic disease influence the outcome of carotid endarterectomy? A 10-year single center experience. Surgery. Apr 2008;143(4):519–525
  21. Akbari CM, Pomposelli FB, Gibbons GW, et al. Diabetes mellitus: a risk factor for carotid endarterectomy?. Journal of Vascular Surgery. Jun 1997;25(6):1070–1075discussion 1075–1076
  22. Ballotta E, Da Giau G, Renon L. Is diabetes mellitus a risk factor for carotid endarterectomy? A prospective study. Surgery. Feb 2001;129(2):146–152
  23. Diagnosis and classification of diabetes mellitus. Diabetes Care. Jan 2006;29(Suppl. 1):S43–S48
  24. Dunkelgrun M, Schreiner F, Schockman DB, et al. Usefulness of preoperative oral glucose tolerance testing for perioperative risk stratification in patients scheduled for elective vascular surgery. American Journal of Cardiology. Feb 15 2008;101(4):526–529
  25. Feringa HH, Vidakovic R, Karagiannis SE, et al. Impaired glucose regulation, elevated glycated haemoglobin and cardiac ischaemic events in vascular surgery patients. Diabetic Medicine. Mar 2008;25(3):314–319
  26. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac surgery: executive summary: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines (writing committee to revise the 2002 guidelines on perioperative cardiovascular evaluation for noncardiac surgery): developed in collaboration with the American Society of Echocardiography, American Society of Nuclear Cardiology, Heart Rhythm Society, Society of Cardiovascular Anesthesiologists, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, and Society for Vascular Surgery. Circulation. Oct 23 2007;116(17):1971–1996
  27. Hertzer NR, Beven EG, Young JR, et al. Coronary artery disease in peripheral vascular patients. A classification of 1000 coronary angiograms and results of surgical management. Annals of Surgery. Feb 1984;199(2):223–233
  28. Kertai MD, Boersma E, Bax JJ, et al. A meta-analysis comparing the prognostic accuracy of six diagnostic tests for predicting perioperative cardiac risk in patients undergoing major vascular surgery. Heart. Nov 2003;89(11):1327–1334
  29. Kraunz RF, Kennedy JW. Ultrasonic determination of left ventricular wall motion in normal man. Studies at rest and after exercise. American Heart Journal. Jan 1970;79(1):36–43
  30. Fleisher LA, Beckman JA, Brown KA, et al. ACC/AHA 2007 Guidelines on perioperative cardiovascular evaluation and care for noncardiac Surgery. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines on perioperative cardiovascular evaluation for noncardiac surgery). Circulation. Sep 27 2007;
  31. Poldermans D, Bax JJ, Schouten O, et al. Should major vascular surgery be delayed because of preoperative cardiac testing in intermediate-risk patients receiving Beta-blocker therapy with tight heart rate control?. Journal of the American College of Cardiology. 2006;48(5):964–969
  32. Pellikka PA, Nagueh SF, Elhendy AA, et al. American society of echocardiography recommendations for performance, interpretation, and application of stress echocardiography. Journal of the American Society of Echocardiography. 2007;20(9):1021–1041
  33. McNeill AJ, Fioretti PM, el-Said SM, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dobutamine stress echocardiography. American Journal of Cardiology. Jul 1 1992;70(1):41–46
  34. Picano E, Pingitore A, Conti U, et al. Enhanced sensitivity for detection of coronary artery disease by addition of atropine to dipyridamole echocardiography. European Heart Journal. Sep 1993;14(9):1216–1222
  35. Armstrong WF, Pellikka PA, Ryan T, et al. Stress echocardiography: recommendations for performance and interpretation of stress echocardiography. Stress Echocardiography Task Force of the Nomenclature and Standards Committee of the American Society of Echocardiography. Journal of the American Society of Echocardiography. Jan 1998;11(1):97–104
  36. Gibbons RJ, Balady GJ, Bricker JT, et al. ACC/AHA 2002 guideline update for exercise testing: summary article. A report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Committee to Update the 1997 Exercise Testing Guidelines). Journal of the American College of Cardiology. Oct 16 2002;40(8):1531–1540
  37. Balady GJ, Larson MG, Vasan RS, et al. Usefulness of exercise testing in the prediction of coronary disease risk among asymptomatic persons as a function of the Framingham risk score. Circulation. Oct 5 2004;110(14):1920–1925
  38. Rywik TM, O'Connor FC, Gittings NS, et al. Role of nondiagnostic exercise-induced ST-segment abnormalities in predicting future coronary events in asymptomatic volunteers. Circulation. Nov 26 2002;106(22):2787–2792
  39. Lyerly GW, Sui X, Church TS, et al. Maximal exercise electrocardiography responses and coronary heart disease mortality among men with diabetes mellitus. Circulation. May 27 2008;117(21):2734–2742
  40. Noguchi Y, Nagata-Kobayashi S, Stahl JE, et al. A meta-analytic comparison of echocardiographic stressors. The International Journal of Cardiovascular Imaging. Apr–Jun 2005;21(2–3):189–207
  41. Kwok Y, Kim C, Grady D, et al. Meta-analysis of exercise testing to detect coronary artery disease in women. American Journal of Cardiology. Mar 1 1999;83(5):660–666
  42. Elhendy A, Arruda AM, Mahoney DW, et al. Prognostic stratification of diabetic patients by exercise echocardiography. Journal of the American College of Cardiology. May 2001;37(6):1551–1557
  43. Garrido IP, Peteiro J, Garcia-Lara J, et al. Prognostic value of exercise echocardiography in patients with diabetes mellitus and known or suspected coronary artery disease. American Journal of Cardiology. Jul 1 2005;96(1):9–12
  44. Poldermans D, Arnese M, Fioretti PM, et al. Improved cardiac risk stratification in major vascular surgery with dobutamine-atropine stress echocardiography. Journal of the American College of Cardiology. 1995;26(3):648–653
  45. Sicari R, Ripoli A, Picano E, et al. Perioperative prognostic value of dipyridamole echocardiography in vascular surgery: a large-scale multicenter study in 509 patients. EPIC (Echo Persantine International Cooperative) Study Group. Circulation. Nov 9 1999;100(19 Suppl):II269–II274
  46. Eichelberger JP, Schwarz KQ, Black ER, et al. Predictive value of dobutamine echocardiography just before noncardiac vascular surgery. American Journal of Cardiology. Sep 1 1993;72(7):602–607
  47. Shaw LJ, Eagle KA, Gersh BJ, et al. Meta-analysis of intravenous dipyridamole-thallium-201 imaging (1985 to 1994) and dobutamine echocardiography (1991 to 1994) for risk stratification before vascular surgery. Journal of the American College of Cardiology. 1996;27(4):787–798
  48. Hennessy TG, Codd MB, Kane G, et al. Evaluation of patients with diabetes mellitus for coronary artery disease using dobutamine stress echocardiography. Coronary Artery Disease. Mar–Apr 1997;8(3–4):171–174
  49. Kamalesh M, Matorin R, Sawada S. Prognostic value of a negative stress echocardiographic study in diabetic patients. American Heart Journal. Jan 2002;143(1):163–168
  50. Cortigiani L, Bigi R, Sicari R, et al. Prognostic value of pharmacological stress echocardiography in diabetic and nondiabetic patients with known or suspected coronary artery disease. Journal of the American College of Cardiology. Feb 7 2006;47(3):605–610
  51. van der Vaart MG, Meerwaldt R, Slart RH, et al. Application of PET/SPECT imaging in vascular disease. European Journal of Vascular and Endovascular Surgery. May 2008;35(5):507–513
  52. Vesely MR, Dilsizian V. Nuclear cardiac stress testing in the era of molecular medicine. Journal of Nuclear Medicine. Mar 2008;49(3):399–413
  53. Beattie WS, Abdelnaem E, Wijeysundera DN, et al. A meta-analytic comparison of preoperative stress echocardiography and nuclear scintigraphy imaging. Anesthesia and Analgesia. Jan 2006;102(1):8–16
  54. Beller GA, Zaret BL. Contributions of nuclear cardiology to diagnosis and prognosis of patients with coronary artery disease. Circulation. Mar 28 2000;101(12):1465–1478
  55. Boucher CA, Brewster DC, Darling RC, et al. Determination of cardiac risk by dipyridamole-thallium imaging before peripheral vascular surgery. The New England Journal of Medicine. Feb 14 1985;312(7):389–394
  56. Husmann L, Wiegand M, Valenta I, et al. Diagnostic accuracy of myocardial perfusion imaging with single photon emission computed tomography and positron emission tomography: a comparison with coronary angiography. The International Journal of Cardiovascular Imaging. Jun 2008;24(5):511–518
  57. Miller TD, Rajagopalan N, Hodge DO, et al. Yield of stress single-photon emission computed tomography in asymptomatic patients with diabetes. American Heart Journal. May 2004;147(5):890–896
  58. Wackers FJ, Young LH, Inzucchi SE, et al. Detection of silent myocardial ischemia in asymptomatic diabetic subjects: the DIAD study. Diabetes Care. Aug 2004;27(8):1954–1961
  59. De Lorenzo A, Lima RS, Siqueira-Filho AG, et al. Prevalence and prognostic value of perfusion defects detected by stress technetium-99 m sestamibi myocardial perfusion single-photon emission computed tomography in asymptomatic patients with diabetes mellitus and no known coronary artery disease. American Journal of Cardiology. Oct 15 2002;90(8):827–832
  60. Hashimoto J, Suzuki T, Nakahara T, et al. Preoperative risk stratification using stress myocardial perfusion scintigraphy with electrocardiographic gating. Journal of Nuclear Medicine. Mar 2003;44(3):385–390
  61. Zarich SW, Cohen MC, Lane SE, et al. Routine perioperative dipyridamole 201Tl imaging in diabetic patients undergoing vascular surgery. Diabetes Care. Apr 1996;19(4):355–360
  62. Bai J, Hashimoto J, Nakahara T, et al. Preoperative risk evaluation in diabetic patients without angina. Diabetes Research and Clinical Practice. Aug 2008;81(2):150–154
  63. Van de Werf F, Ardissino D, Betriu A, et al. Management of acute myocardial infarction in patients presenting with ST-segment elevation. The Task Force on the Management of acute myocardial infarction of the European Society of Cardiology. European Heart Journal. Jan 2003;24(1):28–66
  64. Bassand JP, Hamm CW, Ardissino D, et al. Guidelines for the diagnosis and treatment of non-ST-segment elevation acute coronary syndromes. European Heart Journal. Jul 2007;28(13):1598–1660
  65. Fox K, Garcia MA, Ardissino D, et al. Guidelines on the management of stable angina pectoris: executive summary: the Task Force on the Management of Stable Angina Pectoris of the European Society of Cardiology. European Heart Journal. Jun 2006;27(11):1341–1381
  66. Silber S, Albertsson P, Aviles FF, et al. Guidelines for percutaneous coronary interventions. The Task Force for Percutaneous Coronary Interventions of the European Society of Cardiology. European Heart Journal. Apr 2005;26(8):804–847
  67. Eagle KA, Rihal CS, Mickel MC, et al. Cardiac risk of noncardiac surgery: influence of coronary disease and type of surgery in 3368 operations. CASS Investigators and University of Michigan Heart Care Program. Coronary Artery Surgery Study. Circulation. Sep 16 1997;96(6):1882–1887
  68. Hassan SA, Hlatky MA, Boothroyd DB, et al. Outcomes of noncardiac surgery after coronary bypass surgery or coronary angioplasty in the Bypass Angioplasty Revascularization Investigation (BARI). American Journal of Medicine. Mar 2001;110(4):260–266
  69. Landesberg G, Mosseri M, Wolf YG, et al. Preoperative thallium scanning, selective coronary revascularization, and long-term survival after major vascular surgery. Circulation. Jul 15 2003;108(2):177–183
  70. Poldermans D, Schouten O, Vidakovic R, et al. A clinical randomized trial to evaluate the safety of a noninvasive approach in high-risk patients undergoing major vascular surgery: the DECREASE-V Pilot Study. Journal of the American College of Cardiology. May 1 2007;49(17):1763–1769
  71. Brilakis ES, Banerjee S, Berger PB. Perioperative management of patients with coronary stents. Journal of the American College of Cardiology. Jun 5 2007;49(22):2145–2150
  72. McFalls EO, Ward HB, Moritz TE, et al. Coronary-artery revascularization before elective major vascular surgery. The New England Journal of Medicine. Dec 30 2004;351(27):2795–2804
  73. Garcia S, Moritz TE, Ward HB, et al. Usefulness of revascularization of patients with multivessel coronary artery disease before elective vascular surgery for abdominal aortic and peripheral occlusive disease. American Journal of Cardiology. 2008;102(7):809–813
  74. Durazzo AE, Machado FS, Ikeoka DT, et al. Reduction in cardiovascular events after vascular surgery with atorvastatin: a randomized trial. Journal of Vascular Surgery. May 2004;39(5):967–975discussion 975–966
  75. Mangano DT, Layug EL, Wallace A, et al. Effect of atenolol on mortality and cardiovascular morbidity after noncardiac surgery. Multicenter Study of Perioperative Ischemia Research Group. The New England Journal of Medicine. Dec 5 1996;335(23):1713–1720
  76. Poldermans D, Bax JJ, Kertai MD, et al. Statins are associated with a reduced incidence of perioperative mortality in patients undergoing major noncardiac vascular surgery. Circulation. Apr 15 2003;107(14):1848–1851
  77. Poldermans D, Boersma E, Bax JJ, et al. The effect of bisoprolol on perioperative mortality and myocardial infarction in high-risk patients undergoing vascular surgery. Dutch Echocardiographic Cardiac Risk Evaluation Applying Stress Echocardiography Study Group. The New England Journal of Medicine. Dec 9 1999;341(24):1789–1794
  78. Schouten O, Bax JJ, Dunkelgrun M, et al. Statins for the prevention of perioperative cardiovascular complications in vascular surgery. Journal of Vascular Surgery. 2006;44(2):419–424
  79. Juul AB, Wetterslev J, Gluud C, et al. Effect of perioperative beta blockade in patients with diabetes undergoing major non-cardiac surgery: randomised placebo controlled, blinded multicentre trial. BMJ. Jun 24 2006;332(7556):1482
  80. Liao JK. Clinical implications for statin pleiotropy. Current Opinion In Lipidology. Dec 2005;16(6):624–629
  81. JBS 2 . Joint British Societies' guidelines on prevention of cardiovascular disease in clinical practice. Heart. Dec 2005;91(Suppl. 5):v1–v52
  82. Patrono C. Aspirin as an antiplatelet drug. The New England Journal of Medicine. May 5 1994;330(18):1287–1294
  83. Collaborative overview of randomised trials of antiplatelet therapy–II: Maintenance of vascular graft or arterial patency by antiplatelet therapy. Antiplatelet Trialists' Collaboration. BMJ. Jan 15 1994;308(6922):159–168

PII: S1521-690X(09)00003-7

doi: 10.1016/j.beem.2009.01.002

Best Practice & Research Clinical Endocrinology & Metabolism
Volume 23, Issue 3 , Pages 361-373 , June 2009

Article Tools